The Patent Finder

Inhibitors of Bruton's Tyrosine Kinase

Pharmacyclics, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 39 of these applications claim priority to application 60/826,720, filed Sep 22, 2006. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 7,514,444Inhibitors of Bruton's Tyrosine Kinase
In force
 · Medium confidence
Pharmacyclics LLCIn force
Medium confidence
US 7,960,396Inhibitors of Bruton's Tyrosine Kinase
In force
 · Medium confidence
Pharmacyclics LLCIn force
Medium confidence
US 8,158,786Inhibitors of Bruton's Tyrosine Kinase
In force
 · Medium confidence
Pharmacyclics LLCIn force
Medium confidence
US 8,232,280Inhibitors of Bruton's Tyrosine Kinase
In force
 · Low confidence
Pharmacyclics LLCIn force
Low confidence
US 8,236,812Inhibitors of Bruton's Tyrosine Kinase
In force
 · High confidence
Pharmacyclics LLCIn force
High confidence
US 8,399,470Inhibitors of Bruton's Tyrosine Kinase
In force
 · Low confidence
Pharmacyclics LLCIn force
Low confidence
US 8,476,284Inhibitors of Bruton's Tyrosine Kinase
In force
 · Low confidence
Pharmacyclics LLCIn force
Low confidence
US 8,497,277Inhibitors of Bruton's Tyrosine Kinase
In force
 · Low confidence
Pharmacyclics LLCIn force
Low confidence
US 8,501,751Inhibitors of Bruton's Tyrosine Kinase
In force
 · Medium confidence
Pharmacyclics LLCIn force
Medium confidence
US 8,552,010Inhibitors of Bruton's Tyrosine Kinase
In force
 · High confidence
Pharmacyclics LLCIn force
High confidence
58 more patents in this group · Pro
10 of 68 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 68, including 44 expiring within the 18 months from Nov 15, 2026.
Upgrade to Pro
45 of these are in force and held by Pharmacyclics, Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited